Anavex Life Sciences (AVXL) Equity Ratio (2011 - 2025)
Anavex Life Sciences recorded quarterly Equity Ratio of 0.95 in Q4 2025, up 4.19% quarter-over-quarter from 0.91 in Q3 2025, and up 6.48% year-over-year from 0.89 in Q4 2024.
Anavex Life Sciences' Equity Ratio history runs 15 years deep, the most recent figure standing at 0.95 for Q4 2025.
- In Q4 2025, Equity Ratio rose 6.48% year-over-year to 0.95; the TTM figure through Dec 2025 stood at 0.95 (up 6.48% YoY), while the FY2025 annual figure was 0.91, up 3.01% from the prior year.
- Equity Ratio came in at 0.95 for Q4 2025 at Anavex Life Sciences, up from 0.91 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.95 in Q4 2025 to a low of 0.85 in Q1 2025.
- A 5-year average of 0.92 and a median of 0.92 in 2023 frame the typical range for Equity Ratio.
- Across the five-year window, Equity Ratio rose 21.01% in 2021 and decreased 8.81% in 2025, its largest moves.
- Anavex Life Sciences' Equity Ratio stood at 0.93 in 2021, then decreased by 2.38% to 0.91 in 2022, then advanced by 0.54% to 0.92 in 2023, then slipped by 2.34% to 0.89 in 2024, then gained by 6.48% to 0.95 in 2025.
- According to Business Quant data, Equity Ratio over the past three periods registered 0.95, 0.91, and 0.89 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 0.04 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 0.42 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.73 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.77 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 0.21 |
| 10 | Anavex Life Sciences | 266.20 Mn | 134.45 Mn | - | 0.95 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.95 |
| Sep 30, 2025 | 0.91 |
| Jun 30, 2025 | 0.89 |
| Mar 31, 2025 | 0.85 |
| Dec 31, 2024 | 0.89 |
| Sep 30, 2024 | 0.89 |
| Jun 30, 2024 | 0.92 |
| Mar 31, 2024 | 0.93 |
| Dec 31, 2023 | 0.92 |
| Sep 30, 2023 | 0.92 |
| Jun 30, 2023 | 0.93 |
| Mar 31, 2023 | 0.91 |
| Dec 31, 2022 | 0.91 |
| Sep 30, 2022 | 0.93 |
| Jun 30, 2022 | 0.94 |
| Mar 31, 2022 | 0.95 |
| Dec 31, 2021 | 0.93 |
| Sep 30, 2021 | 0.93 |
| Jun 30, 2021 | 0.94 |
| Mar 31, 2021 | 0.91 |
| Dec 31, 2020 | 0.85 |
| Sep 30, 2020 | 0.79 |
| Jun 30, 2020 | 0.78 |
| Mar 31, 2020 | 0.80 |
| Dec 31, 2019 | 0.83 |
| Sep 30, 2019 | 0.80 |
| Jun 30, 2019 | 0.96 |
| Mar 31, 2019 | 0.84 |
| Dec 31, 2018 | 0.88 |
| Sep 30, 2018 | 0.85 |
| Jun 30, 2018 | 0.88 |
| Mar 31, 2018 | 0.87 |
| Dec 31, 2017 | 0.90 |
| Sep 30, 2017 | 0.93 |
| Jun 30, 2017 | 0.94 |
| Sep 30, 2016 | 0.66 |
| Jun 30, 2015 | 0.82 |
| Mar 31, 2015 | 0.74 |
| Dec 31, 2014 | 0.07 |
| Sep 30, 2014 | 0.03 |
| Jun 30, 2014 | 0.80 |
| Mar 31, 2014 | 0.82 |
| Dec 31, 2013 | -11.07 |
| Sep 30, 2013 | -6.26 |
| Jun 30, 2013 | -1,021.08 |
| Mar 31, 2013 | -7,052.95 |
| Dec 31, 2012 | -41.66 |
| Sep 30, 2012 | -218.59 |
| Jun 30, 2012 | -99.29 |
| Mar 31, 2012 | -15.32 |
| Sep 30, 2011 | -5.63 |